Publications by authors named "Fidel Silveira Leal"
Article Synopsis
- The study aimed to evaluate how effective bexagliflozin is in lowering glycated hemoglobin (HbA1c) and monitoring side effects in patients with type 2 diabetes (T2DM).
- Six randomized, placebo-controlled clinical trials involving a total of 3,111 patients were analyzed, revealing that bexagliflozin significantly reduced HbA1c, fasting plasma glucose, blood pressure, and body weight compared to placebo.
- The findings concluded that bexagliflozin improves clinical outcomes in T2DM patients without increasing the risk of side effects, confirming its efficacy as a treatment option.
Oral lesions related to the novel Coronavirus Disease 2019 (COVID-19) have been increasingly described; however, clinical and epidemiological information is still scant. Although a diversity of therapeutic strategies for the management of these lesions are present in the literature, one can note a lack of standardization and doubtful effectiveness. Thus, the present study aimed to report a series of cases in which a combination of antimicrobial photodynamic therapy (aPDT) and photobiomodulation therapy (PBMT) was used for orofacial lesions in patients suffering from COVID-19.
View Article and Find Full Text PDF